Pediatric growth hormone deficiency (PGHD) is a genetic condition that affects your child’s physical development. Hormone replacement therapy can help promote growth, and a new injection now makes it ...

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few other ...

Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally-occurring ...

The primary sign of growth hormone deficiency in children is short stature. Adults may have decreased muscle mass and increased body fat, as well as other problems such as heart disease and depression ...

Human growth hormone is important in many aspects of growth and development. For children living with growth hormone deficiency, it can involve more than just physical growth differences. Cognitive ...

Skytrofa is a long-acting form of somatropin. Somatropin is also called human growth hormone. Skytrofa is also considered a pegylated somatropin product. Pegylated means the medication is attached to ...

Bone health is critically influenced by the balance of growth hormone signalling, with both growth hormone deficiency (GHD) and acromegaly demonstrating significant but contrasting impacts on the ...

Growth hormone replacement therapy improves physical fitness, lifestyle habits, and quality of life in children with growth ...

Children with growth hormone deficiency (GHD) have differences in gut microbiota and microbial metabolites from both individuals with idiopathic short stature (ISS) and healthy controls, suggesting an ...

Sogroya is administered by subcutaneous injection once weekly. The Food and Drug Administration (FDA) has approved Sogroya ® (somapacitan-beco) for the treatment of pediatric patients aged 2.5 years ...